Delivery Order SPE2DB22D3501-SPE2DB26FTF94
Award Date 10/27/25
Potential Completion Date 10/28/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,612.16 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Gadavist 7.5 mmol/7.5 ml vials. The contract, classified as firm fixed price with no set-aside designation, is scheduled for completion by September 15, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a pediatric or diagnostic imaging pharmaceutical product supporting federal medical...
- The Defense Logistics Agency awarded a $2,809.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gadavist 15 mmol/15 mL vials, a gadolinium-based contrast agent used in magnetic resonance imaging procedures. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, was competitively awarded without set-aside provisions and is scheduled for completion by September 3, 2025. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order valued at $4,657.14 to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials on September 23, 2025, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement of pharmaceutical inventory to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a $1,501.90 delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Gadavist 10 mmol/10 ml vials. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $1,136.62 to AmerisourceBergen Drug Corp for Gadavist 1 mmol/mL bulk vial (30 mL) on June 17, 2025, with completion scheduled for June 18, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier of...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.90 to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials on September 22, 2025. This is a firm fixed price delivery order with an ultimate completion date of September 23, 2025, with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,674.00 to AmerisourceBergen Drug Corp for Gadavist 15 mmol/15 ml vials on May 30, 2025, with completion expected by June 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor headquartered in Conshohocken, Pennsylvania. The product will be delivered to the same location, supporting federal medical supply requirements. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gadavist 15 mmol/15 ml vials with a ceiling value of $2,101.84. This non-competitive, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 mL vials with a ceiling value of $1,501.90. This non-competitive, firm fixed-price delivery order was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Gadavist is a contrast agent used in medical imaging procedures, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.18 to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Gadavist is a gadolinium-based contrast agent used in medical imaging procedures, reflecting the...